Supply Chain Intelligence

Oramed Pharmaceuticals Inc. Supply Chain

ORMP supply chain intelligence for Oramed Pharmaceuticals Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

ORMP ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

5Suppliers
2Customers
3Debt Items
20Related Chains

Oramed Pharmaceuticals Inc. Suppliers

TickerNameConfidenceEvidence
LFWD Lifeward Ltd. 92% At the Notes Closing, Lifeward issued to the Company (i) $9,000,000.00 aggregate principal amount of the Notes with an initial conversion price equal to $5.40 per share
LFWD Lifeward Ltd. 92% Reciprocal relationship from LFWD graph: Reciprocal relationship from ORMP graph: Reciprocal relationship from LFWD graph: Reciprocal relationship from ORMP graph: Reciprocal relationship from LFWD g…
SCLX Scilex Holding Company 92% Pursuant to the Warrant Agreement, the Company deferred its right to receive an amortization payment scheduled to be paid by Scilex on October 1, 2025 as set forth in the amortization schedule includ…
SCLX Scilex Holding Company 92% Reciprocal relationship from SCLX graph: Reciprocal relationship from ORMP graph: Pursuant to the Warrant Agreement, the Company deferred its right to receive an amortization payment scheduled to be …
SMNR Semnur Pharmaceuticals, Inc. 72% Reciprocal relationship from SMNR graph: o other available therapies. Health Technology Assessment (“HTA”) of medicinal products is becoming an increasingly common part of the pricing and reimburseme…

Oramed Pharmaceuticals Inc. Customers

TickerNameConfidenceEvidence
LFWD Lifeward Ltd. 92% Reciprocal relationship from LFWD graph: Reciprocal relationship from ORMP graph: Reciprocal relationship from LFWD graph: Reciprocal relationship from ORMP graph: Reciprocal relationship from LFWD g…
SCLX Scilex Holding Company 92% Reciprocal relationship from SCLX graph: Reciprocal relationship from ORMP graph: Reciprocal relationship from SCLX graph: Pursuant to the Warrant Agreement, Oramed deferred its right to receive an a…

Oramed Pharmaceuticals Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ORMP-DEBT Debt stack $825,000 90% Market cache reports total debt of $825,000.
ORMP-DEBT-11593 Warrants outstanding: 20000 90% xbrl warrant detail from xbrl 2025-12-31.
ORMP-DEBT-11594 Xbrl Convertible 90% xbrl convertible detail from xbrl 2013-08-31.

Oramed Pharmaceuticals Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Oramed Pharmaceuticals Inc..

Oramed Pharmaceuticals Inc. Ownership

HolderNameConfidenceEvidence
ORMP-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 72 tracked holders.

Oramed Pharmaceuticals Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
DVLT Datavault AI Inc. 100.00 2
BMYMP Bristol-Myers Squibb Co 100.00 2
HRZN Horizon Technology Finance Corporation 100.00 2
IINN Inspira Technologies Oxy B.H.N. Ltd. 100.00 2
KRNT Kornit Digital Ltd. 100.00 2
SSYS Stratasys Ltd. 100.00 2
SMNR Semnur Pharmaceuticals, Inc. 100.00 1 ['supplier']
SNYNF Sanofi 100.00 2
MCK McKesson Corporation 100.00 2
LIGAND LIGAND 100.00 2
ORAMED ORAMED 100.00 2
A Agilent Technologies, Inc. 100.00 2
AARD Aardvark Therapeutics, Inc. 100.00 2
COLL Collegium Pharmaceutical, Inc. 100.00 2
BMY Bristol-Myers Squibb Company 100.00 2
SCLX Scilex Holding Company 59.25 1 ['customer', 'supplier']
LFWD Lifeward Ltd. 59.25 1 ['customer', 'supplier']
OISHI OISHI 50.00 2
SCILEX SCILEX 50.00 2
LENDER LENDER 50.00 2
View ORMP supply chain intel →

Explore the full interactive supply chain map for Oramed Pharmaceuticals Inc..

Open ORMP supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map